K J Thomson, N J Saunders, J G Simpson, P H Whiting
{"title":"Renal structure and function in streptozotocin-diabetic rats treated with cyclosporin A.","authors":"K J Thomson, N J Saunders, J G Simpson, P H Whiting","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The effect of cyclosporin A (CsA), administered daily by gavage at 20 mg/kg body weight, on renal structure and function was investigated in normal and streptozotocin-diabetic male adult Sprague-Dawley rats over 12 weeks. In the non-diabetic animals CsA caused a progressive decrease in glomerular filtration rate and increased enzymuria. In contrast, the diabetic state was associated with massive increases in both enzymuria and urine flow rates, but a trend towards increased urea and creatinine clearance rates. CsA treatment of diabetic animals did not significantly alter the above parameters, nor affect circulating glucose levels, and trough serum CsA concentrations were similar in both diabetic and non-diabetic animals. The kidneys from CsA-treated non-diabetic animals showed chronic tubular damage. In the streptozotocin groups, the only morphological abnormality which could be related to diabetes was excess glycogen deposition in distal renal tubules. CsA-treatment of these groups was not associated with structural enhancement of either the drug's nephrotoxicity or the diabetes-related changes. Indeed the results indicate that the diabetic state affords some protection against the functional aspects of CsA-nephrotoxicity.</p>","PeriodicalId":9248,"journal":{"name":"British journal of experimental pathology","volume":"70 4","pages":"405-14"},"PeriodicalIF":0.0000,"publicationDate":"1989-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040564/pdf/brjexppathol00148-0014.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of experimental pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The effect of cyclosporin A (CsA), administered daily by gavage at 20 mg/kg body weight, on renal structure and function was investigated in normal and streptozotocin-diabetic male adult Sprague-Dawley rats over 12 weeks. In the non-diabetic animals CsA caused a progressive decrease in glomerular filtration rate and increased enzymuria. In contrast, the diabetic state was associated with massive increases in both enzymuria and urine flow rates, but a trend towards increased urea and creatinine clearance rates. CsA treatment of diabetic animals did not significantly alter the above parameters, nor affect circulating glucose levels, and trough serum CsA concentrations were similar in both diabetic and non-diabetic animals. The kidneys from CsA-treated non-diabetic animals showed chronic tubular damage. In the streptozotocin groups, the only morphological abnormality which could be related to diabetes was excess glycogen deposition in distal renal tubules. CsA-treatment of these groups was not associated with structural enhancement of either the drug's nephrotoxicity or the diabetes-related changes. Indeed the results indicate that the diabetic state affords some protection against the functional aspects of CsA-nephrotoxicity.
研究了环孢素A (cyclosporin A, CsA)每天以20 mg/kg体重灌胃给药对正常和链脲佐菌素-糖尿病雄性成年sd大鼠肾脏结构和功能的影响。在非糖尿病动物中,CsA引起肾小球滤过率进行性降低和酶血症增加。相比之下,糖尿病状态与酶血症和尿流率的大量增加有关,但尿素和肌酐清除率有增加的趋势。CsA治疗糖尿病动物没有显著改变上述参数,也不影响循环葡萄糖水平,糖尿病动物和非糖尿病动物的谷血清CsA浓度相似。经csa处理的非糖尿病动物肾脏显示慢性肾小管损伤。在链脲佐菌素组中,唯一可能与糖尿病相关的形态学异常是远端肾小管中过量的糖原沉积。这些组的csa治疗与药物肾毒性或糖尿病相关改变的结构增强无关。事实上,结果表明糖尿病状态对csa肾毒性的功能方面提供了一定的保护。